EFFECT OF FIBRIN AND FIBRINOGEN PROTEOLYSIS PRODUCTS ON CLOT PHYSICAL PROPERTIES.
Explore the source record for details and available documents.
Biophysical Phenomena↗
Biomedical subjects
S SHERRY
Publications and source records attributed to S SHERRY.
THE DEVELOPMENT OF UROKINASE AS A THROMBOLYTIC AGENT. MAINTENANCE OF A SUSTAINED THROMBOLYTIC STATE IN MAN BY ITS INTRAVENOUS INFUSION.
Explore the source record for details and available documents.
Angiography↗
THE ASSAY OF UROKINASE PREPARATIONS FOR CONTAMINATION WITH THROMBOPLASTIC MOIETIES.
Explore the source record for details and available documents.
Aminocaproates↗
FIBRINOLYTIC BLEEDING AND ITS MANAGEMENT.
Explore the source record for details and available documents.
Aminocaproates↗
FIBRINOLYTIC BLEEDING AND ITS CONTROL.
Explore the source record for details and available documents.
Blood Coagulation Factors↗
PARTIAL PURIFICATION AND PROPERTIES OF THE PLASMINOGEN ACTIVATOR FROM PIG HEART.
Explore the source record for details and available documents.
Animals↗
ABNORMAL PLASMINOGEN-PLASMIN SYSTEM ACTIVITY (FIBRINOLYSIS) IN PATIENTS WITH HEPATIC CIRRHOSIS: ITS CAUSE AND CONSEQUENCES.
Explore the source record for details and available documents.
Alanine Transaminase↗
FIBRINOLYSIS.
Explore the source record for details and available documents.
Blood Coagulation Disorders↗
ASSAY OF UROKINASE PREPARATIONS WITH THE SYNTHETIC SUBSTRATE ACETYL-L-LYSINE METHYL ESTER.
Explore the source record for details and available documents.
Arginine↗
ASSAY OF PLASMA THROMBOLYTIC ACTIVITY WITH FLUORESCEIN-LABELED CLOTS.
Explore the source record for details and available documents.
Blood Coagulation Tests↗
CURRENT STATUS OF THROMBOLYTIC THERAPY.
Explore the source record for details and available documents.
Antibodies↗
FIBRINOLYSIS AND CLINICAL MEDICINE.
Explore the source record for details and available documents.
Clinical Medicine↗
Fibrinolytic mechanisms and the development of thrombolytic therapy.
Explore the source record for details and available documents.
Fibrinolysis↗
Influence of pH, ionic strength, neutral ions, and thrombin on fibrin polymerization.
Explore the source record for details and available documents.
Fibrin↗
Inhibition of fibrin polymerization by fibrinogen proteolysis products.
Explore the source record for details and available documents.
Fibrin↗
Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products.
Explore the source record for details and available documents.
Blood Coagulation Disorders↗
Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. II. The significance, mechanism and consequences of defective fibrin polymerization.
Explore the source record for details and available documents.
Blood Coagulation Disorders↗
Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. III. Demonstration of abnormal clot structure by electron microscopy.
Explore the source record for details and available documents.
Blood Coagulation Disorders↗